UnitedHealth Group Incorporated (NYSE:UNH) is Ulland Investment Advisors LLC’s 3rd Largest Position

Ulland Investment Advisors LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,249 shares of the healthcare conglomerate’s stock after selling 210 shares during the period. UnitedHealth Group comprises 7.0% of Ulland Investment Advisors LLC’s investment portfolio, making the stock its 3rd biggest position. Ulland Investment Advisors LLC’s holdings in UnitedHealth Group were worth $6,975,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of UNH. Robbins Farley acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $25,000. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $26,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC lifted its stake in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL purchased a new position in UnitedHealth Group in the first quarter valued at about $35,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on UNH shares. HSBC restated a “reduce” rating and issued a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Barclays began coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective on the stock. Bank of America reiterated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Piper Sandler decreased their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $579.33.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Price Performance

UNH stock opened at $490.07 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a market capitalization of $451.81 billion, a PE ratio of 20.56, a price-to-earnings-growth ratio of 1.33 and a beta of 0.54. The company’s fifty day moving average price is $504.98 and its 200-day moving average price is $518.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the prior year, the business posted $5.34 earnings per share. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s payout ratio is 31.54%.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.